Chemizon Expands Collaboration With Takeda

Chemizon has reported that Takeda will continue, and further expand its current research collaboration that utilizes Chemizon’s Discovery Platform. The expansion will be effective beginning the 1st of August, 2009.

Tony Piscopio, chairman and CEO of Optomagic, said: “We are pleased that Takeda, one of Chemizon’s earliest collaborators, has chosen to further extend and expand their collaboration with us.

“This third expansion of the Chemizon-Takeda research partnership is a credit to our scientific team, and validates our efforts in achieving the strategic objectives that were laid out by Takeda. We look forward to a long and mutually beneficial relationship,” he added.

Chemizon is a collaborative drug discovery services organization with operations in South Korea, China and the US.

Located in Osaka, Japan, Takeda is a research-based global pharmaceuticals company.